LSD1 inhibition improved tumor immunogenicity and promoted T cell infiltration, and thus inhibition of LSD1 in combination with PD-1/PD-L1 blockade was suggested as a novel cancer treatment strategy (19). Here, KDM1A is linked to neoplasm.